Clinical Trial Update: Pioglitazone in Patients With Mood Disorders [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated pioglitazone in patients with mood disorders, including major depressive disorder and insulin resistance. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Major Depressive Disorder

Drugs mentioned

• Actos (Pioglitazone)

Snippet

Sponsor: Stanford University | Conditions: Major Depressive Disorder, Insulin Resistance | Phase 4 | Status: COMPLETED | Results posted: 2017-05-10